<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Start-ups and their investors filing requisite declarations not to be subjected to any scrutiny regarding valuations of share premiums</title>
    <link>https://www.taxtmi.com/news?id=21589</link>
    <description>Start-ups and their investors who file prescribed declarations and return disclosures will not be subject to scrutiny of share premium valuations; an e-verification mechanism will establish investor identity and fund source. CBDT will implement administrative safeguards requiring supervisory approval before Assessing Officers may carry out inquiries in these cases. The valuation immunity is extended to Category-II Alternative Investment Funds. Additional measures include relaxations for carry forward and set off of start-up losses, extension and easing of capital gains reinvestment exemption, a dedicated Doordarshan start-up programme, and a scheme offering investment-linked tax incentives for mega-manufacturing in sunrise technologies.</description>
    <language>en-us</language>
    <pubDate>Fri, 05 Jul 2019 14:15:11 +0530</pubDate>
    <lastBuildDate>Fri, 05 Jul 2019 14:15:11 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=577808" rel="self" type="application/rss+xml"/>
    <item>
      <title>Start-ups and their investors filing requisite declarations not to be subjected to any scrutiny regarding valuations of share premiums</title>
      <link>https://www.taxtmi.com/news?id=21589</link>
      <description>Start-ups and their investors who file prescribed declarations and return disclosures will not be subject to scrutiny of share premium valuations; an e-verification mechanism will establish investor identity and fund source. CBDT will implement administrative safeguards requiring supervisory approval before Assessing Officers may carry out inquiries in these cases. The valuation immunity is extended to Category-II Alternative Investment Funds. Additional measures include relaxations for carry forward and set off of start-up losses, extension and easing of capital gains reinvestment exemption, a dedicated Doordarshan start-up programme, and a scheme offering investment-linked tax incentives for mega-manufacturing in sunrise technologies.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 05 Jul 2019 14:15:11 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=21589</guid>
    </item>
  </channel>
</rss>